The LDN Book, Volume Two The Latest Research on How Low Dose Naltrexone Could Revolutionize Treatment for PTSD, Pain, IBD, Lyme Disease, Dermatologic Conditions, and More

【電子書籍なら、スマホ・パソコンの無料アプリで今すぐ読める!】


The LDN Book, Volume Two The Latest Research on How Low Dose Naltrexone Could Revolutionize Treatment for PTSD, Pain, IBD, Lyme Disease, Dermatologic Conditions, and More

楽天Kobo電子書籍ストア

3,490 円 (税抜き)

A comprehensive examination of Low Dose Naltrexoneーa little-known drug with big potential **"**

LDN

raises hopes of reversing memory loss in old age."ーthe Guardian A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination. LDN, originally prescribed in higher doses as a treatment for opioid addiction, works by blocking opioid receptors, thereby stimulating the production of endorphins, mitigating the inflammatory process, and stabilizing the immune response. Prescribed off-label and administered in small daily doses, this generic drug has proven useful in treating many different ailments. Expanding on the information presented in The LDN Book, Volume 1, which showcased LDN’s efficacy in treating conditions such as lupus, thyroiditis, autism spectrum disorder, and chronic fatigue, Volume 2 highlights the latest clinical trials, case studies, and research with explanations from a dozen medical professionals on how they are using LDN to help patients suffering from: Chronic pain Parkinson’s disease Dermatologic conditions Traumatic brain injury Lyme disease and more The LDN Book, Volume 2 is both a resource for practitioners, pharmacists, and patients, and a renewed call for further research on the healing potential of this generic drug.画面が切り替わりますので、しばらくお待ち下さい。
※ご購入は、楽天kobo商品ページからお願いします。
※切り替わらない場合は、こちら をクリックして下さい。
※このページからは注文できません。

この商品の詳細を調べる


本・雑誌・コミック » 洋書 » COMPUTERS & SCIENCE
Guardian -label explanations highlights spectrum